Brief: Biogen Canada Provides Update on Draft Recommendation Supporting Expanded SPINRAZA Reimbursement for SMA
26/10/2026 16:44
BRIEF-Biogen Canada Provides Update on Draft Recommendation Supporting Expanded SPINRAZA Reimbursement for SMA Oct 26 (Reuters) - Biogen Canada:
BIOGEN CANADA PROVIDES UPDATE ON CDA DRAFT RECOMMENDATION SUPPORTING EXPANDED PUBLIC REIMBURSEMENT OF SPINRAZA™ FOR CANADIANS WITH SMA
BIOGEN CANADA: DRAFT RECOMMENDATION DOES NOT RESULT IN IMMEDIATE PROVINCIAL DRUG COVERAGE CHANGES; PROVINCIAL FUNDING DECISIONS STILL REQUIRED
((((Reuters.Briefs@thomsonreuters.com));))
Recent news on Biogen
See all newsUS RESEARCH ROUNDUP-Autodesk, Metlife, Rollins
Brief: Biogen Says DZP Plus Soc Meets Primary Endpoint Of BICLA Response At Week 48
Brief: Biogen Provides Update On Private Payer Coverage For Zurzuvae™ (Zuranolone)
US RESEARCH ROUNDUP-Eli Lilly, General Dynamics, S&P Global
US RESEARCH ROUNDUP-Baker Hughes, Brinker International, GE Vernova